Ever Source Wealth Advisors, LLC Biogen Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,004 shares of BIIB stock, worth $285,089. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,004
Previous 992
102.02%
Holding current value
$285,089
Previous $135,000
85.93%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
131MCall Options Held
2.84MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.46 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.25 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.06 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$683 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...